Assessment of plasma concentrations of (-)-epigallocatechin gallate in mice following administration of a dose reflecting consumption of a standard green tea beverage

Food Chemistry

Volumn 128, Issue 1, 2011, Pages 7-13

  Dube, Admire ^a   Nicolazzo, Joseph A ^a   Larson, Ian ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

( ) Epigallocatechin gallate; Green tea; HPLC UV; Plasma exposure; Stabilization

Indexed keywords

ASCORBIC ACIDS; COMPARATIVE EVALUATIONS; EPIGALLOCATECHIN GALLATE; EX-VIVO; GREEN TEA; HPLC METHOD; HPLC/UV; ORAL ADMINISTRATION; PHARMACOKINETIC STUDIES; PLASMA CONCENTRATION; PLASMA EXPOSURE; PLASMA SAMPLES; TIME CURVES;

BEVERAGES; CONCENTRATION (PROCESS); KETONES; ORGANIC ACIDS; PHOSPHORUS COMPOUNDS; SODIUM; STABILIZATION; STANDARDS;

PLASMAS;

ASCORBIC ACID; EDETATE CALCIUM DISODIUM; EPIGALLOCATECHIN GALLATE; TRIS(2 CARBOXYETHYL)PHOSPHINE;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG STABILITY; EX VIVO STUDY; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; TEA; TIME TO MAXIMUM PLASMA CONCENTRATION;

MUS;

EID: 79954422723     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2011.02.038     Document Type: Article

References (40)

1. A.J. Bailer Testing for the equality of area under the curves when using destructive measurement techniques Journal of Pharmacokinetics and Pharmacodynamics 16 3 1988 303 309
2. D.A. Balentine, S.A. Wiseman, and L.C.M. Bouwens The chemistry of tea flavonoids Critical Reviews in Food Science and Nutrition 37 8 1997 693 704 (Pubitemid 127349613)
3. K.B. Bischoff, R.L. Dedrick, D.S. Zaharko, and J.A. Longstreth Methotrexate pharmacokinetics Journal of Pharmaceutical Sciences 60 8 1971 1128 1133
4. Y. Cai, N.D. Anavy, and H.-H. Sherry Chow Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats Drug Metabolism and Disposition 30 11 2002 1246 1249 (Pubitemid 35265832)
5. L. Chen, M.-J. Lee, H. Li, and C.S. Yang Absorption, distribution, and elimination of tea polyphenols in rats Drug Metabolism and Disposition 25 9 1997 1045 1050 (Pubitemid 27396491)
6. H.H. Chow Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E Cancer Epidemiology Biomarkers & Prevention 10 1 2001 53 58
7. A. Dube, K. Ng, J.A. Nicolazzo, and I. Larson Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution Food Chemistry 122 3 2010 662 667
8. A. Dube, J.A. Nicolazzo, and I. Larson Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate European Journal of Pharmaceutical Sciences 41 2 2010 219 225
9. N.A. Épshtein Validation of HPLC techniques for pharmaceutical analysis Pharmaceutical Chemistry Journal 38 4 2004 212 228 (Pubitemid 39162893)
10. J.C. Han, and G.Y. Han A procedure for quantitative determination of tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol Analytical Biochemistry 220 1 1994 5 10
11. T. Kuzuhara, M. Suganuma, and H. Fujiki Green tea catechin as a chemical chaperone in cancer prevention Cancer Letters 261 1 2008 12 20
12. J.D. Lambert, J. Hong, D.H. Kim, V.M. Mishin, and C.S. Yang Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3- gallate in mice The Journal of Nutrition 134 8 2004 1948 1952 (Pubitemid 39031322)
13. J.D. Lambert, S.-J. Kwon, J. Ju, M. Bose, M.-J. Lee, and J. Hong Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate Carcinogenesis 29 10 2008 2019 2024
14. J.D. Lambert, M.-J. Lee, L. Diamond, J. Ju, J. Hong, and M. Bose Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues Drug Metabolism and Disposition 34 1 2006 8 11 (Pubitemid 43042639)
15. J.D. Lambert, M.-J. Lee, H. Lu, X. Meng, J.J.J. Hong, and D.N. Seril Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice Journal of Nutrition 133 12 2003 4172 4177 (Pubitemid 37505494)
16. J.D. Lambert, S. Sang, J. Hong, S.-J. Kwon, M.-J. Lee, and C.-T. Ho Peracetylation as a means of enhancing in-vitro bioactivity and bioavailability of epigallocatechin-3-gallate Drug Metabolism and Disposition 34 12 2006 2111 2116 (Pubitemid 44837773)
17. J.D. Lambert, S. Sang, and C.S. Yang Biotransformation of green tea polyphenols and the biological activities of those metabolites Molecular Pharmaceutics 4 6 2007 819 825
18. J.D. Lambert, and C.S. Yang Mechanisms of cancer prevention by tea constituents Journal of Nutrition 133 10 2003 3262S 3267S (Pubitemid 37222254)
19. L.-C. Lin, M.-N. Wang, T.-Y. Tseng, Sung, and T.-H. Tsai Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution Journal of Agricultural and Food Chemistry 55 4 2007 1517 1524
20. H. Lu, X. Meng, C. Li, S. Sang, C. Patten, and S. Sheng Glucuronides of tea catechins: Enzymology of biosynthesis and biological activities Drug Metabolism and Disposition 31 4 2003 452 461 (Pubitemid 36378523)
21. C.C. Manach Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies The American Journal of Clinical Nutrition 81 1S 2005 230S 242S
22. X. Meng, S. Sang, N. Zhu, H. Lu, S. Sheng, and M.-J. Lee Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats Chemical Research in Toxicology 15 8 2002 1042 1050 (Pubitemid 34977270)
23. M. Mochizuki, S.-i. Yamazaki, K. Kano, and T. Ikeda Kinetic analysis and mechanistic aspects of autoxidation of catechin Biochimica et Biophysica Acta (BBA) - General Subjects 1569 1-3 2002 35 44 (Pubitemid 34165555)
24. C. Morand, C. Manach, J. Donovan, and C. Remesy Preparation and characterization of flavonoid metabolites present in biological samples P. Lester, Methods in enzymology 2001 Academic Press pp. 83-96
25. D.G. Nagle, D. Ferreira, and Y.-D. Zhou Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives Phytochemistry 67 17 2006 1849 1855 (Pubitemid 44291411)
26. J.R. Nedelman, E. Gibiansky, and D.T.W. Lau Applying Bailer's method for AUC confidence intervals to sparse sampling Pharmaceutical Research 12 1 1995 124 128
27. V.G. Raneva, Y. Shimizu, and H. Shimasaki Antioxidant activity in plasma and tissue distribution of (-)-epigallocatechin gallate after oral administration to rats Journal of Oleo Science 54 5 2005 289 298
28. A. Rojas Ascorbic acid destruction in aqueous model systems: An additional discussion Journal of the Science of Food and Agriculture 81 15 2001 1433 1439 (Pubitemid 34003922)
29. S. Sang, I. Yang, B. Buckley, C.-T. Ho, and C.S. Yang Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate: Studied by real-time mass spectrometry combined with tandem mass ion mapping Free Radical Biology and Medicine 43 3 2007 362 371 (Pubitemid 46977623)
30. J. Sehm, J. Polster, and M.W. Pfaffl Effects of varied EGCG and (+)-catechin concentrations on proinflammatory cytokines mRNA expression in ConA-stimulated primary white blood cell cultures Journal of Agricultural and Food Chemistry 53 17 2005 6907 6911 (Pubitemid 41260740)
31. A. Smith, B. Giunta, P.C. Bickford, M. Fountain, J. Tan, and R.D. Shytle Nanolipidic particles improve the bioavailability and [alpha]-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease International Journal of Pharmaceutics 389 1-2 2010 207 212
32. T. Sun Bioavailability and metabolism of tea catechins in human subjects Tea and Tea Products 2008 CRC Press
33. U. Ullmann, J. Haller, J.P. Decourt, N. Girault, J. Girault, and A.S. Richard-Caudron A single ascending dose study of epigallocatechin gallate in healthy volunteers The Journal of International Medical Research 31 2 2003 88 101 (Pubitemid 36553307)
34. J.B. Vaidyanathan, and T. Walle Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2 The Journal of Pharmacology and Experimental Therapeutics 307 2 2003 745 752 (Pubitemid 37310692)
35. H. Wang, G.J. Provan, and K. Helliwell Tea flavonoids: Their functions, utilisation and analysis Trends in Food Science & Technology 11 4-5 2000 152 160 (Pubitemid 32122540)
36. J. Yuan Estimation of variance for AUC in animal studies Journal of Pharmaceutical Sciences 82 7 1993 761 763 (Pubitemid 23315700)
37. J. Zaleski, S.K. Bansal, and T. Gessner Formation of glucuronide, sulphate and glutathione conjugates of benzo[a]pyrene metabolites in hepatocytes isolated from inbred strains of mice Carcinogenesis 4 11 1983 1359 1366 (Pubitemid 14249311)
38. N.T. Zaveri Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications Life Sciences 78 18 2006 2073 2080
39. M. Zhu, Y. Chen, and R.C. Li Pharmacokinetics and system linearity of tea catechins in rat Xenobiotica 31 1 2001 51 60 (Pubitemid 32337060)
40. Q.Y. Zhu, A. Zhang, D. Tsang, Y. Huang, and Z.-Y. Chen Stability of green tea catechins Journal of Agricultural and Food Chemistry 45 12 1997 4624 4628 (Pubitemid 127485815)